# Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?

> **NCT02799316** · NA · UNKNOWN · sponsor: **Sherief Abd-Elsalam** · enrollment: 100 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **OTHER:** HBV core antibodies testing. • Real time PCR testing.

## Key facts

- **NCT ID:** NCT02799316
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799316, "Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02799316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*